glp-1 obesity drugs pipeline Agonists For In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH GLP-1-based therapies for diabetes, obesity

It may have neuroprotective benefits that promote neuroplasticity and neuronal survival

Bile duct dilationdilated bile ducts lined by cuboidal epithelium

doi: 10.1136/annrheumdis-2014-206792 99

Potential effects include: Improved cellular repair Reduced age-related decline Enhanced resilience to stress Better recovery capacity Longevity and Lifespan Research Animal studies have reported: Increased lifespan Improved health span Reduced age-related pathology Researchers continue to investigate whether similar effects may occur in humans

Problmes digestifs : Le glutathion protge de l'inflammation observe dans les cas de gastrite, d'ulcres gastroduodnaux, de pancratite et d'inflammation intestinale, y compris l'ulcre du clon et la maladie de Crohn [17]